← Home
Danaher
-9.57%
Machinery & equipment / Science and technology-based products and services
Press Releases
| Date | Press release |
|---|---|
| 2025-04-29 10:07:00 | Kytopen And Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative Crispr-mediated Cellular Engineering Workflow Kytopen and aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. high transgene expression and improved safety profile of aldveron’s nanoplasmid™ vector technology and the gentle gene-delivery of kytopen’s flowfect tx™ platform with unlimited scale, together offer enhanced crispr-mediated t-cell engineering resulting in high yields. |
| 2025-04-22 06:00:00 | Danaher Reports First Quarter 2025 Results Washington , april 22, 2025 /prnewswire/ -- danaher corporation (nyse: dhr) (the \"company\") today announced results for the quarter ended march 28, 2025. key first quarter 2025 results net earnings were $1.0 billion, or $1.32 per diluted common share and non-gaap adjusted diluted net earnings per common share were $1.88. |
| 2025-03-20 16:15:00 | Danaher Schedules First Quarter 2025 Earnings Conference Call Washington , march 20, 2025 /prnewswire/ -- danaher corporation (nyse: dhr) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on tuesday, april 22, 2025 beginning at 8:00 a.m. et and lasting approximately one hour. |
| 2025-03-10 08:30:00 | Beckman Coulter Announces Fda Clearance Of Dxc 500i Clinical Analyzer, An Integrated Clinical Chemistry And Immunoassay System The new dxc 500i analyzer offers flexibility and scalability with broad chemistry and immunoassay assay menu brea, calif. , march 10, 2025 /prnewswire/ -- beckman coulter diagnostics, a clinical diagnostics leader, today announced that the new dxc 500i clinical analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the u.s. food and drug administration. |
| 2025-02-25 16:15:00 | Danaher To Present At Td Cowen Health Care Conference Washington , feb. 25, 2025 /prnewswire/ -- danaher corporation (nyse: dhr) announced that president and chief executive officer, rainer m. blair, will be presenting at the td cowen healthcare conference in boston, massachusetts on wednesday, march 5, 2025 at 10:30 a.m. |
| 2025-02-24 07:48:00 |
|
| 2025-02-20 16:45:00 |
|
| 2025-02-20 16:15:00 |
|
| 2025-01-29 06:00:00 |
|
| 2025-01-21 07:26:00 |
|
| 2025-01-15 08:30:00 |
|
| 2025-01-13 16:15:00 |
|
| 2025-01-09 16:15:00 |
|
| 2025-01-06 16:15:00 |
|
| 2025-01-02 16:05:00 |
|
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Legal